- 专利标题： Isoflavonoid compositions and methods for the treatment of cancer
-
申请号： US17193335申请日： 2021-03-05
-
公开(公告)号： US11723893B2公开(公告)日： 2023-08-15
- 发明人: Ofir Moreno
- 申请人： MEI Pharma, Inc.
- 申请人地址： US CA San Diego
- 专利权人： MEI Pharma, Inc.
- 当前专利权人： MEI Pharma, Inc.
- 当前专利权人地址： US CA San Diego
- 代理机构： Wilson Sonsini Goodrich & Rosati
- 主分类号： A61K31/353
- IPC分类号： A61K31/353 ; C07D311/58 ; A61K47/40 ; A61P35/00 ; A61K31/337 ; A61K31/555 ; A61K9/00 ; A61K9/51 ; A61K33/243 ; A61K45/06
摘要：
Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
公开/授权文献
信息查询
IPC分类:
